Translate this page into:
Authors' response
*For correspondence: drjagatram@gmail.com
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.
We appreciate the authors Gurnani and Kaur1 for their constructive comments. This review was written at a time when many clinical findings were not known. We have also started tele-ophthalmology services at our institute and have separate cubicles for the examination of patients with conjunctivitis or those whose Aarogya Setu app shows red/high risk of infection. Once again, we thank the authors for the time and effort they put in bringing out many important points which are relevant in the COVID era.
References
- Impact of the COVID-19 pandemic on clinical ophthalmology. Indian J Med Res 2020:152.
- [Google Scholar]
